Folate-Fluorescein (UB-TT170)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Folate-Fluorescein (UB-TT170), covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma [Phase 1]